1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
Liquid Biopsy Global Product Analysis: Instrumentation, Ancillaries, Kits, Consumables, Reagents, Methods, Applications and Clients

Liquid Biopsy Global Product Analysis: Instrumentation, Ancillaries, Kits, Consumables, Reagents, Methods, Applications and Clients

  • May 2017
  • 187 pages
  • ID: 5251491

Summary

Table of Contents

Summary

This market study provides a detailed analysis of laboratory products being used in the liquid biopsy field. These areas include instrumentation, ancillary equipment and systems, kit-based products, assays, consumables, reagents and others. The products profiled relate to all liquid biopsy strategies including circulating tumour cells, exosomes, circulating cell-free DNA (cfDNA), circulating cell-free tumour DNA (ctDNA) and other circulating genetic markers being explored in this field. These products are classified by company suppliers, product names, methods areas and by their applications in the liquid biopsy field. Overall, the study identified 128 company suppliers, 449 individual products by name, 195 method areas and 186 applications relating to liquid biopsy.

The report provides a competitive analysis across all of these product areas in the liquid biopsy field, covering global regions, countries and organisations types (e.g. hospitals, companies and institutes etc) as well as the names of the organisations profiled in this study. In carrying out this market analysis, we profiled over 700 methodology approaches and the associated products used, across all areas of the liquid biopsy field. We also used these findings to develop an extensive study file of more than 1500 organisations globally, where liquid biopsy is used. Our findings also enabled us to determine future liquid biopsy users in the years ahead and these findings (i.e. organisation names, countries etc) are also provided with the report as a source of qualified market leads to report purchasers.

Companies Mentioned


Liquid Biopsy Global Product Analysis covered products supplied by 128 companies that supply laboratory products used in the liquid biopsy field. These products included all cited consumables and reagents (e.g. chemicals, antibodies etc.,), all-in-one isolation kits (e.g. CTC, cfDNA, ctDNA, assays etc) and equipment or instrumentation (e.g. used in CTC, exosome or cell-free nucleic acid analysis, isolation, sample preparation, imaging etc.). These companies related to 449 individual products by name in 195 method areas and 186 applications relating to liquid biopsy. Example companies include Abbott Molecular, AdnaGen, Applied Biosystems, Axygen, BD Biosciences, Beckman Coulter, Becton Dickinson, ClearBridge Biomedics, Janssen, Macherey-Nagel, Systems Biosciences and Thermo Fisher Scientific.

Purpose of Market Study

This market study was carried out to identify new opportunities to suppliers in the liquid biopsy field. Its findings enable supplier to extend the reach of their existing products, as well as identify new market needs. The second, and we believe the most important goal of this study, is to enable suppliers to predict where the greatest developments and opportunities will be found in the liquid biopsy field in the coming years.

‘Liquid Biopsy Global Product Analysis’ was carried out in two phases. The first phase involved a detailed analysis of current and evolving liquid-biopsy liquid biopsy current practices from reagent level upwards. The second phase used this information to identify where the greatest developments in the liquid biopsy field will take place over the next few years. The study file compiled during this study is also supplied to purchasers, alongside the PDF market report.

Market Areas

Global Regions


This market study was carried out in two phases, 1 and 2. Phase 1 of this study (see Purpose of Study) covered 7 regions, namely Asia, Europe, Middle East, North America, Northern Africa, Oceania, South America and Southern Africa and the data are also analysed across major regions too, namely the Americas, EMEA and Asia Pacific. This analysis was based on over 700 liquid biopsy methodology approaches cited by end-users (covering 128 laboratory suppliers, 449 individual products by name, 195 method areas and 186 applications relating to liquid biopsy. In Phase 2 of this study (see Purpose of Study), we used the information obtained on phase 1 in which we used the information obtained in Phase 1 to identify leading market areas and where the greatest market opportunities liquid biopsy field are anticipated to be found over the next few years. We covered the same regions and major regions, while in this case more than 1500 end-user organisations were identified. The compiled study files relating to liquid biopsy end-users in both phases of this study are provided to purchasers alongside the PDF market report.

Countries

Phase 1 of this study (see Purpose of Study) covered 37 countries including United States, China, Japan, Germany, Australia, UK, Spain, South Korea, Italy, Sweden, Canada, France, Greece and Poland. In Phase 2 of this study our analysis covered more than 40 countries, which included all ’top market ranking’ countries identified in Phase 1 of our study.

Organisation Types

Phase 1 of this study (see Purpose of Study) covered 18 organisation types including hospitals, institutes, universities, companies, medical centres and others. In Phase 2 of this study our analysis covered more than 25 organisation types, which included all ’top market ranking’ organisation types identified in Phase 1 of our study.

Circulating Tumour Cells


In Phase 1 of this study (see Purpose of Study) our analysis covered all identified methods and practices relating to the isolation, enrichment, identification, analysis and the study of CTCs in the context of liquid biopsies. In Phase 2 of this study our analysis covered all organisations working with CTCs, as well as other ’top ranking’ market areas, identified in Phase 1 of our study.

Exosomes


In Phase 1 of this study (see Purpose of Study) our analysis covered all identified methods and practices relating to the isolation, enrichment, identification, analysis and study of exosomes in the context of liquid biopsies. In Phase 2 of this study our analysis covered all organisations working with exosomes, as well as other ’top ranking’ market areas, identified in Phase 1 of our study.

Circulating Cell-Free Nucleic Acids

In Phase 1 of this study (see Purpose of Study) our analysis covered all identified methods and practices relating to the isolation, enrichment, identification, analysis and study of circulating cell-free nucleic acids (cfDNA, cfRNA, ctDNA and others) in the context of liquid biopsies. In Phase 2 of this study our analysis covered all organisations working with circulating cell-free nucleic acids (cfDNA, cfRNA, ctDNA and others), as well as other ’top ranking’ market areas, identified in Phase 1 of our study.

Laboratory Suppliers

Our study identified and profiled (by product, method area, applications and other areas) 128 companies that supply products relating to liquid biopsies. These companies cover all of the product areas evaluated in this study including instrumentation, ancillary equipment and systems, kit-based products, assays, reagents and consumables.

Products


This market study provides a detailed analysis of laboratory products (449 identified) that are area being used in the liquid biopsy field. These product areas include instrumentation, ancillary equipment and ancillary systems, kit-based products in all areas and consumables from reagent levels upwards.

Method Areas

This market study carried out a detailed analysis of the method areas relating to the liquid biopsy products profiled in this study. This market analysis identified 195 methodology areas, which were also segmented by application and other sectors covered in this study.

Applications


This market study carried out a detailed analysis of the application areas relating to the liquid biopsy method areas profiled in this study. This market analysis identified 186 applications, which were also segmented by methods and other sectors covered in this study.

Drug R&D


As part of the market analysis carried out in this study, we also analysed the use of liquid biopsy interventions in clinical trials, where these techniques are incorporated as part of the clinical protocols. This identified 448 clinical trials, of which 179 are being progressed by (primarily pharmaceutical and diagnostic) companies. This part of the study included all of the current liquid biopsy methodologies identified earlier in this study (CTCs, exosomes circulating cell-free nucleic acids) and covered clinical trial phase and start dates, which has allowed the growth (numbers of trials) in this sector to be calculated.

Diagnostics


Diagnostics is at the heart of the liquid biopsy field and this study identified diagnostics companies both as suppliers into laboratories and involved in the conduct of clinical trials in this field. These companies have also been segmented across all other areas of the study, notably relating to CTCs, exosomes, circulating cells-free nucleic acids, methods and applications.

Antibodies

Antibodies are very vitally important in the liquid biopsy field, for many different reasons. As part of this study antibodies have been covered in some depth, with 53 different antibodies (21 companies) and 22 conjugated antibodies (10 companies) identified. This antibodies and conjugated antibodies have also been segmented across all other areas of the study, notably relating to CTCs, exosomes, circulating cells-free nucleic acids, methods and applications.

Imaging


Imaging is also important in the liquid biopsy field and as part of this study imaging has been covered this in some depth, where we identified 26 companies and 46 products, systems or platforms or ancillaries. Imaging methods have also been segmented across all other areas of the study, notably relating to CTCs, exosomes, circulating cells-free nucleic acids, methods and applications.

Market Opportunities


The identification of market opportunities was a key goal in the conduct of this market study. Findings relating to opportunities were made through the detailed stratification of products, methods and applications relating to CTCs, exosomes and circulating nucleic acids, which identified where and how these products are being used. Phase 2 of this study also identified more than 1500 end-user organisations in the liquid biopsy field, providing a valuable source of market prospects to suppliers.

Future Use

The future anticipated use liquid biopsy methodologies was analysed in Phase 2 of this study, which used the findings compiled in Phase I to identify the top users globally. This covered the major sectors of the liquid biopsy field, including CTCs, exosomes and circulating cell-free nucleic acids. This part of the study also allowed us to calculate the growth of these activities from market develops seen in the liquid biopsy field between 2014 and 2017.

Market Growth


The future anticipated use liquid biopsy methodologies was also analysed in Phase 2 of this study, which used the findings compiled in Phase I to identify the top users globally. This covered the major sectors of the liquid biopsy field, including CTCs, exosomes and circulating cell-free nucleic acids.

Clients


As part of Phase 1 and Phase 2 of this study, we identified liquid biopsy end-users by organisation name. These are segmented globally and by country and across all other areas of the study, enabling specific activities in this field to be directly linked to the organisations themselves. The compiled data files of phases 1 and 2 of this study are provided to purchasers alongside the PDF market report.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Liquid Biopsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Liquid Biopsy Industry: Forecasts to 2026

  • $ 5795
  • Industry report
  • August 2018
  • by Transparency Market Research

Liquid Biopsy Market: Scope and MethodologyThis report on the global liquid biopsy market analyzes the current and future prospects of the market.The report comprises a comprehensive executive summary, ...

Breast Cancer Liquid Biopsy Market by Circulating Biomarkers, Region, End User, Investments, Market Dynamics, Platform Comparison, Competitive Landscape - Global Forecasts to 2022

Breast Cancer Liquid Biopsy Market: Global Forecasts until 2022

  • $ 5649
  • Industry report
  • August 2018
  • by MarketsandMarkets

Global breast cancer liquid biopsy market projected to grow at a CAGR of 23.1%The global breast cancer liquid biopsy market is estimated to grow at a CAGR of 23.1% from 2017 to 2022, from USD 145.4 million ...

Global Liquid Biopsy Market: Focus on Products and Services, Therapeutic Applications, Clinical Applications, Circulating Biomarkers, Country Analysis (16 Countries), Industry Insights, and Competitive Landscape - Analysis and Forecast, 2018-2028

Global Liquid Biopsy Market: Focus on Products and Services, Therapeutic Applications, Clinical Applications, Circulating Biomarkers, Country Analysis (16 Countries), Industry Insights, and Competitive Landscape - Analysis and Forecast, 2018-2028

  • $ 5000
  • Industry report
  • September 2018
  • by BIS Research

Global Liquid Biopsy Market to Reach $2.94 Billion by 2028Tissue biopsy is the predominant diagnostic procedure that is used for cancer diagnosis and treatment monitoring.Tissue biopsy is essentially dependent ...


ref:plp2017

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on